Company / Revenue
Tango Therapeutics, Inc. Revenue History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$62.4M
FY2025
5-year range
$7.7M / $62.4M
FY2021-FY2025
Trend
+48.3%
vs FY2024
Sector context
#117 of 155
Health Care
What the data says
Tango Therapeutics, Inc.'s revenue of $62M is lower than 75% of companies in the Health Care sector (FY2025). Improved from $37M to $62M over the past 2 years.
Based on SEC 10-K filings.
$62M in FY2025 with a 5-year CAGR of +52.1%.
Improved from $37M to $62M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +19.0%
- 5-Year CAGR
- +52.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 155This company $62.4M Sector average $4.5B
▼
-98.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +52.1%, indicating consistent growth.
- In FY2025, revenue increased 48.3% year-over-year.
- Ranks #117 out of 155 companies in the Health Care sector.
- Lowest revenue in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $62.4M | +48.3% |
| FY2024 | $42.1M | +15.2% |
| FY2023 | $36.5M | -1.4% |
| FY2022 | $37.0M | +383.8% |
| FY2021 | $7.7M | +0.0% |
| FY2020 | $7.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026